Traws Pharma, Inc. Operating Leases, Rent Expense
Traws Pharma, Inc. (TRAW) reported Operating Leases, Rent Expense of $158.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2020-03-27
- Traws Pharma, Inc. operating leases, rent expense for fiscal 2019 was $158.00K, a 4.24% decline from fiscal 2018.
- Traws Pharma, Inc. operating leases, rent expense for fiscal 2018 was $165.00K, a 8.55% increase from fiscal 2017.
- Traws Pharma, Inc. operating leases, rent expense for fiscal 2017 was $152.00K, a 20.42% decline from fiscal 2016.
- Traws Pharma, Inc. operating leases, rent expense for fiscal 2016 was $191.00K, a 33.68% decline from fiscal 2015.
| Period end | Operating Leases, Rent Expense 12 month |
|---|---|
| 2019-12-31 | $158.00K 10-K · filed 2020-03-27 |
| 2018-12-31 | $165.00K 10-K · filed 2020-03-27 |
| 2017-12-31 | $152.00K 10-K · filed 2019-04-01 |
| 2016-12-31 | $191.00K 10-K · filed 2018-03-16 |
| 2015-12-31 | $288.00K 10-K · filed 2017-03-29 |
| 2014-12-31 | $389.00K 10-K · filed 2016-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |